ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 73 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 200 | -17.4% | 0.00% | – |
| Q4 2020 | $1,000 | -50.0% | 242 | -41.1% | 0.00% | – |
| Q3 2020 | $2,000 | -60.0% | 411 | -78.0% | 0.00% | – |
| Q2 2020 | $5,000 | +400.0% | 1,864 | +527.6% | 0.00% | – |
| Q1 2020 | $1,000 | -90.9% | 297 | -89.4% | 0.00% | – |
| Q4 2019 | $11,000 | -73.2% | 2,795 | -65.1% | 0.00% | – |
| Q3 2019 | $41,000 | -14.6% | 7,999 | +5.0% | 0.00% | – |
| Q2 2019 | $48,000 | -11.1% | 7,618 | +0.2% | 0.00% | – |
| Q1 2019 | $54,000 | -16.9% | 7,600 | 0.0% | 0.00% | – |
| Q4 2018 | $65,000 | +1.6% | 7,600 | +138.1% | 0.00% | – |
| Q3 2018 | $64,000 | -9.9% | 3,192 | +17.3% | 0.00% | – |
| Q2 2018 | $71,000 | +18.3% | 2,721 | +8.8% | 0.00% | – |
| Q1 2018 | $60,000 | -31.8% | 2,500 | -3.0% | 0.00% | – |
| Q4 2017 | $88,000 | +8.6% | 2,577 | -32.4% | 0.00% | – |
| Q3 2017 | $81,000 | -54.2% | 3,814 | -62.3% | 0.00% | – |
| Q2 2017 | $177,000 | -5.3% | 10,122 | -5.2% | 0.00% | – |
| Q1 2017 | $187,000 | +1000.0% | 10,677 | +955.0% | 0.00% | – |
| Q4 2016 | $17,000 | – | 1,012 | +7684.6% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 13 | -97.1% | 0.00% | – |
| Q3 2015 | $8,000 | -65.2% | 454 | -47.5% | 0.00% | – |
| Q2 2015 | $23,000 | – | 864 | +6546.2% | 0.00% | – |
| Q4 2014 | $0 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|